Chargement...

Robocath successfully carries out its first robotic coronary angioplasties in humans

24 September 2019

The procedures were performed at Rouen University Hospital and Clinique Pasteur in Toulouse (France) and precede the first clinical study of its kind to be conducted in Europe

Rouen, September 24, 2019 – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces the success of its first two coronary angioplasties performed with assistance from its R-One™ robotic platform. The procedures were performed in France at Rouen University Hospital by Professor…

Learn more

Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

3 September 2019

Rouen, September 3, 2019. – Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, announces today that it has raised €5 million ($5.5M) to support the rollout of its robotic platform in strategic European target markets. The company has also hired Lucien Goffart as CEO.

With twenty years of experience in interventional cardiology, Lucien Goffart has held a number of key positions in leading companies in the sector. He also has a…

Learn more
29 January 2020

High Tech Cardio 2020 - Marseille (France)

#Robocath
Subscribe to our newsletter